We further wanted to assess if the degradation of GATA2 also occurred in prostate cancer cells that rely on GATA2 for proper AR transcriptional function [22], or if GATA2 degradation may be a mechanism of protection from AR activity/differentiation in basal-like prostate epithelial cells. The gene discussed is GATA2; the disease is prostate cancer.